{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T02:33:28Z","timestamp":1771382008663,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"DOI":"10.1007\/s10048-025-00807-w","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T01:58:47Z","timestamp":1739584727000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["ABCB1 c.3435 C\u2009>\u2009T (rs1045642) as a biomarker for carbamazepine efficacy and toxicity in Algerian patients with epilepsy: initial findings report"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5380-4189","authenticated-orcid":false,"given":"Rachda","family":"Riffi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7984-3796","authenticated-orcid":false,"given":"Wefa","family":"Boughrara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3493-2159","authenticated-orcid":false,"given":"Meriem Samia","family":"Aberkane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4364-0748","authenticated-orcid":false,"given":"Wassila","family":"Ilias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8910-7802","authenticated-orcid":false,"given":"Mohamed Sofiane","family":"Bouchetara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4916-8635","authenticated-orcid":false,"given":"Amel Alioua","family":"Berrebbah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2087-8104","authenticated-orcid":false,"given":"Fatma","family":"Belhoucine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6004-019X","authenticated-orcid":false,"given":"Amina","family":"Chentouf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,15]]},"reference":[{"key":"807_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yebeh.2017.10.010","volume":"78","author":"AWC Yuen","year":"2018","unstructured":"Yuen AWC, Keezer MR, Sander JW (2018) Epilepsy is a neurological and a systemic disorder. Epilepsy Behav 78:57\u201361","journal-title":"Epilepsy Behav"},{"key":"807_CR2","doi-asserted-by":"publisher","unstructured":"Giourou E, Stavropoulou-Deli A, Giannakopoulou A, Kostopoulos GK, Koutroumanidis M (2015) In: Voros NS, Antonopoulos CP (eds) Cyberphysical systems for epilepsy and related brain disorders: multi-parametric monitoring and analysis for diagnosis and optimal disease management. Cham, Springer International Publishing., 11\u201338. https:\/\/doi.org\/10.1007\/978-3-319-20049-1_2. Accessed 2 May 2024","DOI":"10.1007\/978-3-319-20049-1_2"},{"key":"807_CR3","unstructured":"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0920121115000030. Accessed 20 Oct 2024"},{"key":"807_CR4","doi-asserted-by":"crossref","unstructured":"Larsen LE, Caestecker S, Stevens L, van Mierlo P, Carrette E, Boon P, ..., Raedt R (2023) Hippocampal seizures differentially modulate locus coeruleus activity and result in consistent time-locked release of noradrenaline in rat hippocampus. Neurobiol Dis 189:106355","DOI":"10.1016\/j.nbd.2023.106355"},{"key":"807_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.eplepsyres.2015.09.001","volume":"117","author":"P Wang","year":"2015","unstructured":"Wang P, Yin T, Ma HY, Liu DQ, Sheng YH, Wang C, Zhou BT (2015) Effects of CYP3A4\/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy. Epilepsy Res 117:52\u201357","journal-title":"Epilepsy Res"},{"key":"807_CR6","doi-asserted-by":"publisher","first-page":"100442","DOI":"10.1016\/j.ebr.2021.100442","volume":"16","author":"NF Abdel Ghaffar","year":"2021","unstructured":"Abdel Ghaffar NF, Asiri RN, AL-Eitan LN, Alamri RS, Alshyarba RM, Alrefeidi FA, Asiri A, Alghamdi MA (2021) Improving public stigma, sociocultural beliefs, and social identity for people with epilepsy in the Aseer region of Saudi Arabia. Epilepsy Behav Rep 16:100442","journal-title":"Epilepsy Behav Rep"},{"issue":"2","key":"807_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000339637","volume":"39","author":"D Moualek","year":"2012","unstructured":"Moualek D, Pacha LA, Abrouk S, Kediha MI, Nouioua S, Aissa LA, Bellatache M, Belarbi S, Slimani S, Khennouf H et al (2012) Multicenter transversal two-phase study to determine a national prevalence of epilepsy in Algeria. Neuroepidemiology 39(2):131\u2013134","journal-title":"Neuroepidemiology"},{"key":"807_CR8","unstructured":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/abs\/10.1002\/phar.1855. Accessed 21 Aug 2024"},{"issue":"7","key":"807_CR9","first-page":"392","volume":"35","author":"MM Goldenberg","year":"2010","unstructured":"Goldenberg MM (2010) Overview of drugs used for epilepsy and seizures:etiology, diagnosis, and treatment. P T Peer-Rev J Formul Manag 35(7):392\u2013415","journal-title":"P T Peer-Rev J Formul Manag"},{"issue":"3","key":"807_CR10","doi-asserted-by":"publisher","first-page":"240","DOI":"10.37349\/ent.2024.00080","volume":"4","author":"A Shahid","year":"2024","unstructured":"Shahid A, Hameed K, Zainab A, Zafar A, Abbas S (2024) Advances in pharmacogenomics: optimizing antiepileptic drug therapy for drug-resistant epilepsy. Explor Neuroprotective Ther 4(3):240\u2013250","journal-title":"Explor Neuroprotective Ther"},{"issue":"2","key":"807_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/00019052-200304000-00013","volume":"16","author":"SM Sisodiya","year":"2003","unstructured":"Sisodiya SM (2003) \/\/ Curr. Opin Neurol 16(2):197","journal-title":"Opin Neurol"},{"key":"807_CR12","unstructured":"https:\/\/databases.lovd.nl\/shared\/genes\/ABCB1. Accessed 29 Aug 2024"},{"key":"807_CR13","unstructured":"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/0005273676901607. Accessed 29 Aug 2024"},{"issue":"4","key":"807_CR14","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s13760-022-01920-5","volume":"122","author":"W Boughrara","year":"2022","unstructured":"Boughrara W, Chentouf A (2022) The ABCB1, ABCC2 and RALBP1 polymorphisms are associated with carbamazepine response in epileptic patient: a systematic review. Acta Neurol Belg 122(4):871\u2013880","journal-title":"Acta Neurol Belg"},{"issue":"5","key":"807_CR15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/epd2.20093","volume":"25","author":"T Tomson","year":"2023","unstructured":"Tomson T, Zelano J, Dang YL, Perucca P (2023) The pharmacological treatment of epilepsy in adults. Epileptic Disorders 25(5):649\u2013669","journal-title":"Epileptic Disorders"},{"key":"807_CR16","doi-asserted-by":"publisher","unstructured":"Riffi R, Boughrara W, Chentouf A, Ilias W, Taieb Ibrahim NM, Alioua Berrebbah A, Belhocine F (2024) CNS Neurol Disord Drug Targets. https:\/\/doi.org\/10.2174\/0118715273298953240529100325. Accessed 29 Aug 2024","DOI":"10.2174\/0118715273298953240529100325"},{"key":"807_CR17","doi-asserted-by":"crossref","unstructured":"Djordjevic N, Jankovic SM, Milovanovic JR (2017) Eur J Drug Metab Pharmacokinet 42(5):729\u2013744","DOI":"10.1007\/s13318-016-0397-3"},{"key":"807_CR18","unstructured":"https:\/\/www.pnas.org\/doi\/abs\/10.1073\/pnas.97.7.3473. Accessed 29 Aug 2024"},{"key":"807_CR19","unstructured":"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S1357303916300433. Accessed 14 Jan 2025"},{"key":"807_CR20","unstructured":"https:\/\/www.nejm.org\/doi\/full\/10.1056\/nejmoa021986. Accessed 4 June 2024"},{"key":"807_CR21","doi-asserted-by":"crossref","unstructured":"Fisher RS (2017) CurrNeurol Neurosci Rep 17(6):48","DOI":"10.1007\/s11910-017-0758-6"},{"key":"807_CR22","unstructured":"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJM200002033420503. Accessed 23 Aug 2024"},{"key":"807_CR23","unstructured":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3904059\/. Accessed 23 Aug 2024"},{"key":"807_CR24","unstructured":"https:\/\/www.tandfonline.com\/doi\/abs\/10.1517\/14622416.6.4.411. Accessed 23 Aug 2024"},{"issue":"1","key":"807_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.yebeh.2007.04.013","volume":"11","author":"P Kwan","year":"2007","unstructured":"Kwan P, Baum L, Wong V, Ng PW, Lui CH, Sin NC, Hui ACF, Yu E, Wong LKS (2007) Association between ABCB1 C3435T polymorphism and drug-resistant epilepsy in Han Chinese. Epilepsy Behav 11(1):112\u2013117","journal-title":"Epilepsy Behav"},{"key":"807_CR26","unstructured":"https:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/17512433.2018.1486707. Accessed 29 Aug 2024"},{"key":"807_CR27","unstructured":"https:\/\/www.sciencedirect.com\/topics\/medicine-and-dentistry\/enzyme-multiplied-immunoassay-technique. Accessed 27 Aug 2024"},{"key":"807_CR28","doi-asserted-by":"crossref","unstructured":"Raj Panday D, Panday KR, Basnet M, Kafle S, Shah B, Rauniar G (2017) Int J Neurorehabilitation 04(01). .https:\/\/www.omicsgroup.org\/journals\/therapeutic-drug-monitoring-of-carbamazepine-2376-0281-1000245.php?aid=85963. Accessed 29 Aug 2024","DOI":"10.4172\/2376-0281.1000245"},{"issue":"11","key":"807_CR29","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1001\/archneur.1980.00500600047009","volume":"37","author":"T Tomson","year":"1980","unstructured":"Tomson T, Tybring G, Bertilsson L, Ekbom K, Rane A (1980) Carbamazepine therapy in trigeminal neuralgia: clinical effects in relation to plasma concentration. Arch Neurol 37(11):699\u2013703","journal-title":"Arch Neurol"},{"issue":"6","key":"807_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/jcla.20083","volume":"19","author":"H Nasiri","year":"2005","unstructured":"Nasiri H, Forouzandeh M, Rasaee MJ, Rahbarizadeh F (2005) Modified salting-out method: high-yield, high-quality genomic DNA extraction from whole blood using laundry detergent. J Clin Lab Anal 19(6):229\u2013232","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"807_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1471-2105-11-173","volume":"11","author":"H-W Chang","year":"2010","unstructured":"Chang H-W, Cheng Y-H, Chuang L-Y, Yang C-H (2010) Confronting two-pair primer design for enzyme-free SNP genotyping based on a genetic algorithm. BMC Bioinformatics 11(1):173","journal-title":"BMC Bioinformatics"},{"key":"807_CR32","doi-asserted-by":"publisher","first-page":"145907","DOI":"10.1016\/j.gene.2021.145907","volume":"805","author":"M-L Zhang","year":"2021","unstructured":"Zhang M-L, Chen X-L, Bai Z-F, Zhao X, Li W-X, Wang X-Y, Zhang H, Chen X-F, Zhang S-Q, Tang J-F et al (2021) ABCB1 c.3435C > T and EPHX1 c.416A > G polymorphisms influence plasma carbamazepine concentration, metabolism, and pharmacoresistance in epileptic patients. Gene 805:145907","journal-title":"Gene"},{"key":"807_CR33","doi-asserted-by":"publisher","first-page":"106785","DOI":"10.1016\/j.eplepsyres.2021.106785","volume":"177","author":"Y-X Fan","year":"2021","unstructured":"Fan Y-X, Zhang Z, Meng J-R, Yin S-J, Wang P, Zhou T, Huang Y-H, Meng R, He G-H (2021) Association of ABCB1 polymorphisms with carbamazepine metabolism and resistance in epilepsy: A meta-analysis. Epilepsy Res 177:106785","journal-title":"Epilepsy Res"},{"issue":"1","key":"807_CR34","first-page":"27","volume":"21","author":"H Meng","year":"2011","unstructured":"Meng H, Guo G, Ren J, Zhou H, Ge Y, Guo Y (2011) \/\/ Epilepsy Behav. EB 21(1):27\u201330","journal-title":"EB"},{"issue":"2","key":"807_CR35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1515\/dmdi-2013-0046","volume":"29","author":"NM Jaramillo","year":"2014","unstructured":"Jaramillo NM, Galindo IF, V\u00e1zquez AO, Cook HJ, LLerena A, L\u00f3pez ML (2014) Pharmacogenetic potential biomarkers for carbamazepine adverse drug reactions and clinical response. Drug Metabol. Drug Interact 29(2):67\u201379","journal-title":"Drug Metabol. Drug Interact"},{"issue":"4","key":"807_CR36","first-page":"410","volume":"31","author":"S-J Wang","year":"2024","unstructured":"Wang S-J, Zhao M-Y, Zhao P-C, Zhang W, Rao G-W (2024) \/\/ Curr. Med Chem 31(4):410\u2013452","journal-title":"Med Chem"},{"key":"807_CR37","unstructured":"https:\/\/link.springer.com\/article\/10.1186\/s41983-024-00859-z. Accessed 20 Oct 2024"},{"key":"807_CR38","unstructured":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1535759720905516. Accessed 12 Aug 2024"},{"issue":"7","key":"807_CR39","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1517\/14656566.2016.1168399","volume":"17","author":"J Gierbolini","year":"2016","unstructured":"Gierbolini J, Giarratano M, Benbadis SR (2016) Carbamazepine-related antiepileptic drugs for the treatment of epilepsy-a comparative review. Expert Opin Pharmacother 17(7):885\u2013888","journal-title":"Expert Opin Pharmacother"},{"key":"807_CR40","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.seizure.2015.06.015","volume":"31","author":"A Chentouf","year":"2015","unstructured":"Chentouf A, Dahdouh A, Guipponi M, Oubaiche ML, Chaouch M, Hamamy H, Antonarakis SE (2015) Familial epilepsy in Algeria: Clinical features and inheritance profiles. Seizure 31:2\u201318","journal-title":"Seizure"},{"issue":"5","key":"807_CR41","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.seizure.2006.02.015","volume":"15","author":"DW Kim","year":"2006","unstructured":"Kim DW, Kim M, Lee SK, Kang R, Lee S-Y (2006) Lack of association between C3435T nucleotide MDR1 genetic polymorphism and multidrug-resistant epilepsy. Seizure 15(5):344\u2013347","journal-title":"Seizure"},{"issue":"1\u20132","key":"807_CR42","first-page":"67","volume":"59","author":"GO Ozgon","year":"2007","unstructured":"Ozgon GO, Bebek N, Gul G, Cine N (2007) Association of MDR1 (C3435T) polymorphism and resistance to carbamazepine in epileptic patients from Turkey. Eur Neurol 59(1\u20132):67\u201370","journal-title":"Eur Neurol"},{"key":"807_CR43","doi-asserted-by":"crossref","unstructured":"Qu J, Zhou BT, Yin JY, Xu XJ, Zhao YC, Lei GH,\u00a0..., Liu ZQ (2012) ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients. CNS Neuroscience & Therapeutics 18(8):647\u2013651","DOI":"10.1111\/j.1755-5949.2012.00336.x"},{"issue":"15","key":"807_CR44","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.2217\/pgs.14.142","volume":"15","author":"X Zhu","year":"2014","unstructured":"Zhu X, Yun W, Sun X, Qiu F, Zhao L, Guo Y (2014) Effects of major transporter and metabolizing enzyme gene polymorphisms on carbamazepine metabolism in chinese patients with epilepsy. Pharmacogenomics 15(15):1867\u20131879","journal-title":"Pharmacogenomics"},{"key":"807_CR45","unstructured":"https:\/\/www.tandfonline.com\/doi\/abs\/10.2217\/14622416.7.4.551. Accessed 29 Aug 2024"},{"issue":"2","key":"807_CR46","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.eplepsyres.2013.11.009","volume":"108","author":"U Shaheen","year":"2014","unstructured":"Shaheen U, Prasad DKV, Sharma V, Suryaprabha T, Ahuja YR, Jyothy A, Munshi A (2014) Significance of MDR1 gene polymorphism C3435T in predicting drug response in epilepsy. Epilepsy Res 108(2):251\u2013256","journal-title":"Epilepsy Res"},{"key":"807_CR47","doi-asserted-by":"crossref","unstructured":"Chouchi M, Kaabachi W, Klaa H, Tizaoui K, Turki IB-Y , Hila L (2017) BMC Neurol 17(1):32","DOI":"10.1186\/s12883-017-0801-x"},{"key":"807_CR48","doi-asserted-by":"crossref","unstructured":"Al-Eitan LN, Al-Dalalah IM, Mustafa MM, Alghamdi MA, Elshammari AK, Khreisat WH, Aljamal HA (2019) Effects of MTHFR and ABCC2 gene polymorphisms on antiepileptic drug responsiveness in Jordanian epileptic patients. Pharmacogenomics Pers Med 87\u201395","DOI":"10.2147\/PGPM.S211490"},{"key":"807_CR49","doi-asserted-by":"crossref","unstructured":"Al-Eitan LN, Al-Dalala IM, Elshammari AK, Khreisat WH, Nimiri AF, Alnaamneh AH, ..., Alghamdi MA (2020) Genetic association of epilepsy and anti-epileptic drugs treatment in jordanian patients. Pharmacogenomics Pers Med 503\u2013510","DOI":"10.2147\/PGPM.S273125"},{"key":"807_CR50","doi-asserted-by":"crossref","unstructured":"AL-Eitan LN, Al-Dalalah IM, Aljamal HA (2019) Saudi Pharm J 27(5):731\u2013737","DOI":"10.1016\/j.jsps.2019.04.009"},{"key":"807_CR51","doi-asserted-by":"crossref","unstructured":"AL-Eitan LN, Al-Dalalah IM, Mustafa MM, Alghamdi MA, Elshammari AK, Khreisat WH, Al-Quasmi MN, Aljamal HA (2019) Pharmacogenomics Pers Med 12:225\u2013233","DOI":"10.2147\/PGPM.S212433"},{"key":"807_CR52","doi-asserted-by":"crossref","unstructured":"Chouchi M, Klaa H, Ben-Youssef Turki I, Hila L (2019) ABCB1 polymorphisms and drug-resistant epilepsy in a Tunisian population. Dis Markers 2019(1):1343650","DOI":"10.1155\/2019\/1343650"},{"key":"807_CR53","doi-asserted-by":"crossref","unstructured":"Leschziner G, Jorgensen AL, Pirmohamed M, Williamson PR, Marson AG, Coffey AJ, ..., Andrew T (2006) Clinical factors and ABCB1 polymorphisms in prediction of antiepileptic drug response: a prospective cohort study. Lancet Neurol 5(8):668\u2013676","DOI":"10.1016\/S1474-4422(06)70500-2"},{"key":"807_CR54","doi-asserted-by":"crossref","unstructured":"Rashid HU, Ullah S, Carr DF, Khattak MIK, Asad MI, Rehman MU, Tipu MK (2024) MolBiol Rep 51(1):191","DOI":"10.1007\/s11033-023-09061-5"},{"issue":"3","key":"807_CR55","doi-asserted-by":"publisher","first-page":"265","DOI":"10.4103\/0022-3859.138739","volume":"60","author":"SR Taur","year":"2014","unstructured":"Taur SR, Kulkarni NB, Gandhe PP, Thelma BK, Ravat SH, Gogtay NJ, Thatte UM (2014) Association of polymorphisms of CYP2C9, CYP2C19, and ABCB1, and activity of P-glycoprotein with response to anti-epileptic drugs. J Postgrad Med 60(3):265\u2013269","journal-title":"J Postgrad Med"},{"issue":"1","key":"807_CR56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2217\/pgs.12.180","volume":"14","author":"YG Puranik","year":"2013","unstructured":"Puranik YG, Birnbaum AK, Marino SE, Ahmed G, Cloyd JC, Remmel RP, Leppik IE, Lamba JK (2013) Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy. Pharmacogenomics 14(1):35\u201345","journal-title":"Pharmacogenomics"},{"key":"807_CR57","doi-asserted-by":"crossref","unstructured":"Dhivya E, Kesavan R, Pradeep NP (2024) Drug Metab Pers Ther 39(1):27\u201334","DOI":"10.1515\/dmpt-2023-0054"},{"issue":"6","key":"807_CR58","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3390\/diagnostics14060602","volume":"14","author":"A Eichhorn","year":"2024","unstructured":"Eichhorn A, Neumann F, B\u00e4umler C, Gutsmann I, Grobe O, Schl\u00fcter F, M\u00fcller S, Krumbholz A (2024) Assessment of the diagnostic performance of fully automated hepatitis E virus (HEV) antibody tests. Diagnostics 14(6):602","journal-title":"Diagnostics"},{"key":"807_CR59","unstructured":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1111\/j.1528-1167.2008.01858.x. Accessed 31 Aug 2024"},{"issue":"7","key":"807_CR60","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1080\/17512433.2018.1486707","volume":"11","author":"I Fricke-Galindo","year":"2018","unstructured":"Fricke-Galindo I, LLerena A, Jung-Cook H, L\u00f3pez-L\u00f3pez M (2018) Carbamazepine adverse drug reactions. Expert Rev Clin Pharmacol 11(7):705\u2013718","journal-title":"Expert Rev Clin Pharmacol"},{"key":"807_CR61","doi-asserted-by":"crossref","unstructured":"Kim WJ, Lee JH, Yi J, Cho YJ, Heo K, Lee SH, ..., Lee MG (2010) A nonsynonymous variation in MRP2\/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy. Pharmacogenet Genomics 20(4):249\u2013256","DOI":"10.1097\/FPC.0b013e328338073a"}],"container-title":["Neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-025-00807-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-025-00807-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-025-00807-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T04:05:15Z","timestamp":1769400315000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10048-025-00807-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,15]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["807"],"URL":"https:\/\/doi.org\/10.1007\/s10048-025-00807-w","relation":{},"ISSN":["1364-6753"],"issn-type":[{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,15]]},"assertion":[{"value":"4 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical board of Neurology Department of the University Hospital of Oran, Algeria approved this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"In accordance with the Declaration of Helsinki, all participants were fully informed about the objectives of the study, and written informed consent was obtained prior to their inclusion. Individuals who chose not to provide consent were excluded from participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial"}}],"article-number":"29"}}